Stay updated on Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Sign up to get notified when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.

Latest updates to the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page history shows a new revision entry v3.3.2 and removal of v3.2.0; these are metadata about revisions rather than study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedA government funding notice explaining potential delays and operating status was removed from the page. The removal does not affect the study data or how to navigate the page.SummaryDifference0.7%

- Check42 days agoChange DetectedDifference0.8%

- Check56 days agoChange DetectedAdds a comprehensive study documentation section (status, design, outcome measures, participant flow, results, adverse events, quality control) with a return date, signaling ongoing research activity.SummaryDifference4%

- Check71 days agoChange DetectedAdded a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision. The page now communicates potential service delays and open NIH Clinical Center status, plus the updated software version.SummaryDifference13%

- Check78 days agoChange DetectedResults have moved from no results posted to results submitted, with a new version tag v3.1.0 replacing v3.0.2.SummaryDifference0.8%

Stay in the know with updates to Lumateperone in Schizophrenia Relapse Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Lumateperone in Schizophrenia Relapse Prevention Clinical Trial page.